Guilford (GLFD) - Steadily Rising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guilford (GLFD) - Steadily Rising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Vinnie who wrote (363)	8/11/2000 7:45:37 AM
From: Jack Hartmann	Read Replies (1) of 496

07:12 ET Business Week Stock : Guilford Pharmaceuticals (GLFD 17 1/2) may have a blockbuster drug in its nerve-regeneration compound, NIL-A. The potential treatment for Parkinson's disease showed good results in preliminary clinical trials. Legg Mason Wood Walker analyst Stefan Loren sees potential sales of $1 bln. Analyst's 12-18 month price target is $45. from beriefing.com Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next